Meijers J C, Vlooswijk R A, Kanters D H, Hessing M, Bouma B N
Department of Haematology, University Hospital, Utrecht, The Netherlands.
Blood. 1988 Oct;72(4):1401-3.
Monoclonal antibodies specific for protein C inhibitor (PCI) partially blocked the inactivation of activated protein C (APC) in plasma, whereas in a purified system, the PCI activity could be completely blocked. The inactivation of APC in normal and in PCI-depleted plasma was similar in the absence of heparin. The addition of heparin did not change the rate of inactivation of APC in PCI-depleted plasma, whereas in normal plasma a rapid phase of inhibition of APC was followed by a slower phase of inhibition. The slower phase was identical to the rate of inhibition of APC in the absence of heparin. After incubation of normal plasma with a monoclonal antibody specific for PCI that blocked its activity, there was no difference in heparin-dependent or heparin-independent inhibition of APC. These results indicate that in the absence of heparin PCI is unable to inactivate APC in a plasma environment.
针对蛋白C抑制剂(PCI)的单克隆抗体部分阻断了血浆中活化蛋白C(APC)的失活,而在纯化系统中,PCI活性可被完全阻断。在无肝素的情况下,正常血浆和PCI缺乏血浆中APC的失活情况相似。添加肝素并未改变PCI缺乏血浆中APC的失活速率,而在正常血浆中,APC的抑制快速期之后是较慢的抑制期。较慢的阶段与无肝素时APC的抑制速率相同。用针对PCI的单克隆抗体孵育正常血浆以阻断其活性后,APC的肝素依赖性或非肝素依赖性抑制没有差异。这些结果表明,在无肝素的情况下,PCI无法在血浆环境中使APC失活。